Business News • PR NewsWire • New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome

New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome

New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome

ATLANTA, May 17, 2013 /PRNewswire/ -- UCB today announced data from a double-blind, placebo-controlled study that found that Neupro® (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure (NSBP) elevations associated with periodic limb movements during...

View More : http://www.prnewswire.com/news-releases/new-study-shows-effect-of-neupro-rotigotine-transdermal-system-on-cardiovascular...

Releted News by prnewswire

PRfact Becomes Ketchum's Exclusive Affiliate in Switzerland

Mark Duval Named Next President of AmCham China

Fi Istanbul's Success Demonstrates Unlimited Market Opportunities in Turkey, the Middle East & North Africa

SAP Consulting Specialists- Harlex Consulting, Release DataSuite v3.0

Bipartisan Policy Center Launches New Citizens for Political Reform Effort Led by former Sen. Olympia Snowe and Sec. Dan Glickman